JAWED MOVANIA: Open Payments
NPI 1447258553 · RADCLIFF, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 39 payments from 11 companies in 2025. Trend: 2023 $172 · 2024 $520 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $171 |
| Axsome Therapeutics, Inc. | 7 | $137 |
| ABBVIE INC. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| PFIZER INC. | 3 | $48 |
| Indivior Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
Products named: CAPLYTA, Auvelity, Kerendia, UBRELVY, SUBLOCADE, BREZTRI, FARXIGA, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
